Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.06% · OPTIONAL
· Electromedical & Electrotherapeutic Apparatus
RESEARCH SNAPSHOTCeribell, Inc.'s latest supported as-filed period reports revenue of $28.1M, 32.5% above the comparable as-filed period; gross margin moved 419 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.06% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -45.78% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 32.54% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 23.98% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 92.32% · CORE
Level · gp.fundamentals.operating_margin
Raw value -71.11% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 32.5%; Operating margin moved 58 bp lower; Operating income decreased 33.6%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents decreased 18.6%; Operating cash flow decreased 70.8%.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Shares outstanding increased 4.7%; SBC / revenue moved 641 bp higher.
2 evidence-backed componentsFree-cash-flow proxy changed -69.4% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
CBLL · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-388299SEC ↗4Sep 10, 2026Period Sep 8, 20260001193125-26-388295SEC ↗4Sep 4, 2026Period Sep 2, 20260001193125-26-383893SEC ↗4Sep 4, 2026Period Sep 2, 20260001193125-26-383891SEC ↗4Aug 25, 2026Period Aug 21, 20260001193125-26-365558SEC ↗4Aug 25, 2026Period Aug 21, 20260001193125-26-365554SEC ↗4Aug 25, 2026Period Aug 21, 20260001193125-26-365552SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 8, 2026Filed Sep 10, 2026 | Foehr DavidSenior VP, Finance and PAO | Option ExerciseDirect | 7,500 | $5 | $35,250 | Form 4 ↗ |
| Sep 8, 2026Filed Sep 10, 2026 | Foehr DavidSenior VP, Finance and PAO | Option ExerciseDirect | 7,500 | $0 | $0 | Form 4 ↗ |
| Sep 8, 2026Filed Sep 10, 2026 | Foehr DavidSenior VP, Finance and PAO | Open Market SaleDirect | 1,755 | $24 | $42,576 | Form 4 ↗ |
| Sep 8, 2026Filed Sep 10, 2026 | Foehr DavidSenior VP, Finance and PAO | Open Market SaleDirect | 7,500 | $24 | $181,875 | Form 4 ↗ |
| Sep 2, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 24.01% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 21.35% · OPTIONAL
Operating income changed -33.6% from the comparable as-filed period.
Operating cash flow changed -70.8% from the comparable as-filed period.
Gross margin changed +419 basis points from the comparable as-filed period.
Revenue changed +32.5% from the comparable as-filed period.
Research & development changed +39.1% from the comparable as-filed period.
Gross profit changed +38.8% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-365550| Chao XingjuanPresident and CEO |
| Open Market SaleDirect |
| 39,540 |
| $25 |
| $973,079 |
| Form 4 ↗ |
| Sep 2, 2026Filed Sep 4, 2026 | Chao XingjuanPresident and CEO | Option ExerciseDirect | 1,446 | $0 | $0 | Form 4 ↗ |
| Sep 2, 2026Filed Sep 4, 2026 | Chao XingjuanPresident and CEO | Option ExerciseDirect | 1,446 | $5 | $6,796 | Form 4 ↗ |
| Sep 2, 2026Filed Sep 4, 2026 | Chao XingjuanPresident and CEO | Option ExerciseDirect | 23,554 | $0 | $0 | Form 4 ↗ |
| Sep 2, 2026Filed Sep 4, 2026 | Chao XingjuanPresident and CEO | Option ExerciseDirect | 23,554 | $5 | $110,704 | Form 4 ↗ |
| Aug 24, 2026Filed Aug 25, 2026 | Foehr DavidSenior VP, Finance and PAO | Open Market SaleDirect | 859 | $24 | $20,573 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 25, 2026 | Chao XingjuanPresident and CEO | Open Market SaleDirect | 6,068 | $24 | $145,753 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 25, 2026 | Manni Joseph S.Chief Revenue Officer | Open Market SaleDirect | 1,361 | $24 | $32,691 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 25, 2026 | Blumberg ScottChief Financial Officer | Open Market SaleDirect | 1,521 | $24 | $36,534 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 25, 2026 | Foehr DavidSenior VP, Finance and PAO | Open Market SaleDirect | 993 | $24 | $23,852 | Form 4 ↗ |
| Aug 21, 2026Filed Aug 25, 2026 | Woo RaymondChief Technology Officer | Open Market SaleDirect | 1,979 | $24 | $47,536 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Blumberg ScottChief Financial Officer | Option ExerciseDirect | 6,179 | $0 | $0 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Blumberg ScottChief Financial Officer | Open Market SaleDirect | 33,512 | $25 | $838,805 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Blumberg ScottChief Financial Officer | Option ExerciseDirect | 27,333 | $9 | $257,204 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Blumberg ScottChief Financial Officer | Option ExerciseDirect | 6,179 | $5 | $29,041 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Blumberg ScottChief Financial Officer | Option ExerciseDirect | 27,333 | $0 | $0 | Form 4 ↗ |